1. Catalog
  2. Phase II PICCOLO Trial Results
Image For Activity Cover
Phase II PICCOLO Trial Results
Results of Phase II PICCOLO Trial are available. Dr. Angeles Alvarez Secord, PI of PICCOLO Trial, and Dr. Wendel Naumann discuss results of MIRV in Recurrent Platinum-Sensitive Ovarian Cancer with High Folate Receptor-Alpha Expression.  
Description

Results of Phase II PICCOLO Trial are available! Data was originally presented on Sunday, September 15, 2024 at ESMO Congress 2024. 

Dr. Angeles Alvarez Secord, PI of PICCOLO Trial, and Dr. Wendel Naumann discuss results of Mirvetuximab Soravtansine (MIRV) in Recurrent Platinum-Sensitive Ovarian Cancer (PSOC) with High Folate Receptor-Alpha (FRα) Expression. 

Presented by:

Angeles Alvarez Secord, MD, MHSc
Professor of Obstetrics and Gynecology
Duke University School of Medicine
USA

Moderated by:
Wendel Naumann, MD 
Director of Minimally Invasive Surgery in Gynecologic Oncology  
Carolinas Medical Center Associate Medical Director of Clinical Trials 
Associate Medical Director of Clinical Trials 
Levine Cancer Institute, Atrium Health 
USA 

Attended previous IGCS webinars? If you have attended IGCS webinars in the past, you may already have an IGCS account and creating a new account is not required. If unsure of your login information, you may reset your information by selecting "Forgot Password" at login or contact education@igcs.org.
Supported in part by
Summary
Availability: On-Demand
Cost: FREE
Create Account
Recommended
Contact education@igcs.org for assistance.
Powered By